June 23, 2009-The European Medicines Agency Has Been Formally Notified By Menarini International Operations Luxembourg S.A. Of Its Decision To Withdraw Its Application For A Centralised Marketing Authorisation For The Medicine Factive (Gemifloxacin), 320 Mg Film-Coated Tablets.
The details can be read here.
No comments:
Post a Comment